BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11238689)

  • 1. Sorting out mutations in human T-cell leukemia virus type 1 proviruses during in vivo clonal expansion.
    Mansky LM
    J Natl Cancer Inst; 2001 Mar; 93(5):336-7. PubMed ID: 11238689
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo.
    Mortreux F; Leclercq I; Gabet AS; Leroy A; Westhof E; Gessain A; Wain-Hobson S; Wattel E
    J Natl Cancer Inst; 2001 Mar; 93(5):367-77. PubMed ID: 11238698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M; Hill SA; Derse D
    Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
    Duc Dodon M; Mesnard JM; Barbeau B
    Med Sci (Paris); 2010 Apr; 26(4):391-6. PubMed ID: 20412744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
    Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
    J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
    Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
    J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-lymphotropic virus type I transcriptional regulation by methylation.
    Saggioro D; Panozzo M; Chieco-Bianchi L
    Cancer Res; 1990 Aug; 50(16):4968-73. PubMed ID: 1696163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonal expansion and genomic characterization of the human T-cell lymphotropic virus type I during the integration process in adult T-cell leukemia/lymphoma].
    Salcedo-Cifuentes M; Cabrera J; Cuesta-Astroz Y; Carrasca E; Eizuru Y; Domínguez MC; Sánchez A; García-Vallejo F
    Biomedica; 2009 Jun; 29(2):218-31. PubMed ID: 20128347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs.
    Tanaka M; Sun B; Fang J; Nitta T; Yoshida T; Kohtoh S; Kikukawa H; Hanai S; Uchida K; Miwa M
    J Virol; 2001 May; 75(9):4420-3. PubMed ID: 11287593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.
    Koiwa T; Hamano-Usami A; Ishida T; Okayama A; Yamaguchi K; Kamihira S; Watanabe T
    J Virol; 2002 Sep; 76(18):9389-97. PubMed ID: 12186921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation.
    Hishizawa M; Imada K; Ishikawa T; Uchiyama T
    Leukemia; 2004 Jan; 18(1):167-9. PubMed ID: 14603340
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle.
    Kootstra NA; Zwart BM; Schuitemaker H
    J Virol; 2000 Feb; 74(4):1712-7. PubMed ID: 10644341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
    Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
    Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.
    Beerens N; Groot F; Berkhout B
    Nucleic Acids Res; 2000 Nov; 28(21):4130-7. PubMed ID: 11058109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction.
    Götte M; Li X; Wainberg MA
    Arch Biochem Biophys; 1999 May; 365(2):199-210. PubMed ID: 10328813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo.
    Leclercq I; Mortreux F; Cavrois M; Leroy A; Gessain A; Wain-Hobson S; Wattel E
    J Virol; 2000 Mar; 74(5):2305-12. PubMed ID: 10666261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.